0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Lisinopril - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-39S8092
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Lisinopril Market Insights Forecast to 2028
BUY CHAPTERS

Lisinopril - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-39S8092
Report
November 2024
Pages:168
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lisinopril - Market Size

The global market for Lisinopril was estimated to be worth US$ 1832 million in 2023 and is forecast to a readjusted size of US$ 2642 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030

Lisinopril - Market

Lisinopril - Market

Lisinopril is typically used for the treatment of high blood pressure, congestive heart failure, acute myocardial infarction (heart attack), and diabetic nephropathy
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lisinopril, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lisinopril by region & country, by Type, and by Application.
The Lisinopril market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lisinopril.
Market Segmentation

Scope of Lisinopril - Market Report

Report Metric Details
Report Name Lisinopril - Market
Forecasted market size in 2030 US$ 2642 million
CAGR 5.4%
Forecasted years 2024 - 2030
Segment by Type:
  • 2.5mg
  • 5mg
  • 10mg
  • 20mg
  • 30mg
  • 40mg
Segment by Application
  • Hospital
  • Drug Store
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, Lek Pharmaceuticals, Lupin, Mylan Pharmaceuticals, Ranbaxy Pharmaceuticals, Novartis, Teva Pharmaceuticals, Vintage Pharmaceuticals, Watson Laboratories, West Ward Pharmaceutical, Wockhardt, Merck Research Laboratories, Astrazeneca, Alvogen, Hikma, Prinston, Accord Hlthcare, CASI Pharms, Invagen Pharms, SUN Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Lisinopril manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Lisinopril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Lisinopril in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Lisinopril - Market size in 2030?

Ans: The Lisinopril - Market size in 2030 will be US$ 2642 million.

Who are the main players in the Lisinopril - Market report?

Ans: The main players in the Lisinopril - Market are Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, Lek Pharmaceuticals, Lupin, Mylan Pharmaceuticals, Ranbaxy Pharmaceuticals, Novartis, Teva Pharmaceuticals, Vintage Pharmaceuticals, Watson Laboratories, West Ward Pharmaceutical, Wockhardt, Merck Research Laboratories, Astrazeneca, Alvogen, Hikma, Prinston, Accord Hlthcare, CASI Pharms, Invagen Pharms, SUN Pharm

What are the Application segmentation covered in the Lisinopril - Market report?

Ans: The Applications covered in the Lisinopril - Market report are Hospital, Drug Store

What are the Type segmentation covered in the Lisinopril - Market report?

Ans: The Types covered in the Lisinopril - Market report are 2.5mg, 5mg, 10mg, 20mg, 30mg, 40mg

1 Market Overview
1.1 Lisinopril Product Introduction
1.2 Global Lisinopril Market Size Forecast
1.2.1 Global Lisinopril Sales Value (2019-2030)
1.2.2 Global Lisinopril Sales Volume (2019-2030)
1.2.3 Global Lisinopril Sales Price (2019-2030)
1.3 Lisinopril Market Trends & Drivers
1.3.1 Lisinopril Industry Trends
1.3.2 Lisinopril Market Drivers & Opportunity
1.3.3 Lisinopril Market Challenges
1.3.4 Lisinopril Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lisinopril Players Revenue Ranking (2023)
2.2 Global Lisinopril Revenue by Company (2019-2024)
2.3 Global Lisinopril Players Sales Volume Ranking (2023)
2.4 Global Lisinopril Sales Volume by Company Players (2019-2024)
2.5 Global Lisinopril Average Price by Company (2019-2024)
2.6 Key Manufacturers Lisinopril Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Lisinopril Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lisinopril
2.9 Lisinopril Market Competitive Analysis
2.9.1 Lisinopril Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Lisinopril Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisinopril as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 2.5mg
3.1.2 5mg
3.1.3 10mg
3.1.4 20mg
3.1.5 30mg
3.1.6 40mg
3.2 Global Lisinopril Sales Value by Type
3.2.1 Global Lisinopril Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lisinopril Sales Value, by Type (2019-2030)
3.2.3 Global Lisinopril Sales Value, by Type (%) (2019-2030)
3.3 Global Lisinopril Sales Volume by Type
3.3.1 Global Lisinopril Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Lisinopril Sales Volume, by Type (2019-2030)
3.3.3 Global Lisinopril Sales Volume, by Type (%) (2019-2030)
3.4 Global Lisinopril Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Lisinopril Sales Value by Application
4.2.1 Global Lisinopril Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lisinopril Sales Value, by Application (2019-2030)
4.2.3 Global Lisinopril Sales Value, by Application (%) (2019-2030)
4.3 Global Lisinopril Sales Volume by Application
4.3.1 Global Lisinopril Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Lisinopril Sales Volume, by Application (2019-2030)
4.3.3 Global Lisinopril Sales Volume, by Application (%) (2019-2030)
4.4 Global Lisinopril Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Lisinopril Sales Value by Region
5.1.1 Global Lisinopril Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lisinopril Sales Value by Region (2019-2024)
5.1.3 Global Lisinopril Sales Value by Region (2025-2030)
5.1.4 Global Lisinopril Sales Value by Region (%), (2019-2030)
5.2 Global Lisinopril Sales Volume by Region
5.2.1 Global Lisinopril Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Lisinopril Sales Volume by Region (2019-2024)
5.2.3 Global Lisinopril Sales Volume by Region (2025-2030)
5.2.4 Global Lisinopril Sales Volume by Region (%), (2019-2030)
5.3 Global Lisinopril Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Lisinopril Sales Value, 2019-2030
5.4.2 North America Lisinopril Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Lisinopril Sales Value, 2019-2030
5.5.2 Europe Lisinopril Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Lisinopril Sales Value, 2019-2030
5.6.2 Asia Pacific Lisinopril Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Lisinopril Sales Value, 2019-2030
5.7.2 South America Lisinopril Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lisinopril Sales Value, 2019-2030
5.8.2 Middle East & Africa Lisinopril Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lisinopril Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lisinopril Sales Value
6.2.1 Key Countries/Regions Lisinopril Sales Value, 2019-2030
6.2.2 Key Countries/Regions Lisinopril Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Lisinopril Sales Value, 2019-2030
6.3.2 United States Lisinopril Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lisinopril Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lisinopril Sales Value, 2019-2030
6.4.2 Europe Lisinopril Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lisinopril Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lisinopril Sales Value, 2019-2030
6.5.2 China Lisinopril Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lisinopril Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lisinopril Sales Value, 2019-2030
6.6.2 Japan Lisinopril Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lisinopril Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lisinopril Sales Value, 2019-2030
6.7.2 South Korea Lisinopril Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lisinopril Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lisinopril Sales Value, 2019-2030
6.8.2 Southeast Asia Lisinopril Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lisinopril Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lisinopril Sales Value, 2019-2030
6.9.2 India Lisinopril Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lisinopril Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Actavis Elizabeth
7.1.1 Actavis Elizabeth Company Information
7.1.2 Actavis Elizabeth Introduction and Business Overview
7.1.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Actavis Elizabeth Lisinopril Product Offerings
7.1.5 Actavis Elizabeth Recent Development
7.2 Apotex
7.2.1 Apotex Company Information
7.2.2 Apotex Introduction and Business Overview
7.2.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Apotex Lisinopril Product Offerings
7.2.5 Apotex Recent Development
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Company Information
7.3.2 Aurobindo Pharma Introduction and Business Overview
7.3.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Aurobindo Pharma Lisinopril Product Offerings
7.3.5 Aurobindo Pharma Recent Development
7.4 Ivax Pharmaceuticals
7.4.1 Ivax Pharmaceuticals Company Information
7.4.2 Ivax Pharmaceuticals Introduction and Business Overview
7.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ivax Pharmaceuticals Lisinopril Product Offerings
7.4.5 Ivax Pharmaceuticals Recent Development
7.5 Lek Pharmaceuticals
7.5.1 Lek Pharmaceuticals Company Information
7.5.2 Lek Pharmaceuticals Introduction and Business Overview
7.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Lek Pharmaceuticals Lisinopril Product Offerings
7.5.5 Lek Pharmaceuticals Recent Development
7.6 Lupin
7.6.1 Lupin Company Information
7.6.2 Lupin Introduction and Business Overview
7.6.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Lupin Lisinopril Product Offerings
7.6.5 Lupin Recent Development
7.7 Mylan Pharmaceuticals
7.7.1 Mylan Pharmaceuticals Company Information
7.7.2 Mylan Pharmaceuticals Introduction and Business Overview
7.7.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Mylan Pharmaceuticals Lisinopril Product Offerings
7.7.5 Mylan Pharmaceuticals Recent Development
7.8 Ranbaxy Pharmaceuticals
7.8.1 Ranbaxy Pharmaceuticals Company Information
7.8.2 Ranbaxy Pharmaceuticals Introduction and Business Overview
7.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Ranbaxy Pharmaceuticals Lisinopril Product Offerings
7.8.5 Ranbaxy Pharmaceuticals Recent Development
7.9 Novartis
7.9.1 Novartis Company Information
7.9.2 Novartis Introduction and Business Overview
7.9.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Novartis Lisinopril Product Offerings
7.9.5 Novartis Recent Development
7.10 Teva Pharmaceuticals
7.10.1 Teva Pharmaceuticals Company Information
7.10.2 Teva Pharmaceuticals Introduction and Business Overview
7.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Teva Pharmaceuticals Lisinopril Product Offerings
7.10.5 Teva Pharmaceuticals Recent Development
7.11 Vintage Pharmaceuticals
7.11.1 Vintage Pharmaceuticals Company Information
7.11.2 Vintage Pharmaceuticals Introduction and Business Overview
7.11.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Vintage Pharmaceuticals Lisinopril Product Offerings
7.11.5 Vintage Pharmaceuticals Recent Development
7.12 Watson Laboratories
7.12.1 Watson Laboratories Company Information
7.12.2 Watson Laboratories Introduction and Business Overview
7.12.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Watson Laboratories Lisinopril Product Offerings
7.12.5 Watson Laboratories Recent Development
7.13 West Ward Pharmaceutical
7.13.1 West Ward Pharmaceutical Company Information
7.13.2 West Ward Pharmaceutical Introduction and Business Overview
7.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.13.4 West Ward Pharmaceutical Lisinopril Product Offerings
7.13.5 West Ward Pharmaceutical Recent Development
7.14 Wockhardt
7.14.1 Wockhardt Company Information
7.14.2 Wockhardt Introduction and Business Overview
7.14.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Wockhardt Lisinopril Product Offerings
7.14.5 Wockhardt Recent Development
7.15 Merck Research Laboratories
7.15.1 Merck Research Laboratories Company Information
7.15.2 Merck Research Laboratories Introduction and Business Overview
7.15.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Merck Research Laboratories Lisinopril Product Offerings
7.15.5 Merck Research Laboratories Recent Development
7.16 Astrazeneca
7.16.1 Astrazeneca Company Information
7.16.2 Astrazeneca Introduction and Business Overview
7.16.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Astrazeneca Lisinopril Product Offerings
7.16.5 Astrazeneca Recent Development
7.17 Alvogen
7.17.1 Alvogen Company Information
7.17.2 Alvogen Introduction and Business Overview
7.17.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Alvogen Lisinopril Product Offerings
7.17.5 Alvogen Recent Development
7.18 Hikma
7.18.1 Hikma Company Information
7.18.2 Hikma Introduction and Business Overview
7.18.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Hikma Lisinopril Product Offerings
7.18.5 Hikma Recent Development
7.19 Prinston
7.19.1 Prinston Company Information
7.19.2 Prinston Introduction and Business Overview
7.19.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Prinston Lisinopril Product Offerings
7.19.5 Prinston Recent Development
7.20 Accord Hlthcare
7.20.1 Accord Hlthcare Company Information
7.20.2 Accord Hlthcare Introduction and Business Overview
7.20.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Accord Hlthcare Lisinopril Product Offerings
7.20.5 Accord Hlthcare Recent Development
7.21 CASI Pharms
7.21.1 CASI Pharms Company Information
7.21.2 CASI Pharms Introduction and Business Overview
7.21.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.21.4 CASI Pharms Lisinopril Product Offerings
7.21.5 CASI Pharms Recent Development
7.22 Invagen Pharms
7.22.1 Invagen Pharms Company Information
7.22.2 Invagen Pharms Introduction and Business Overview
7.22.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Invagen Pharms Lisinopril Product Offerings
7.22.5 Invagen Pharms Recent Development
7.23 SUN Pharm
7.23.1 SUN Pharm Company Information
7.23.2 SUN Pharm Introduction and Business Overview
7.23.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2019-2024)
7.23.4 SUN Pharm Lisinopril Product Offerings
7.23.5 SUN Pharm Recent Development
8 Industry Chain Analysis
8.1 Lisinopril Industrial Chain
8.2 Lisinopril Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lisinopril Sales Model
8.5.2 Sales Channel
8.5.3 Lisinopril Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Lisinopril Market Trends
    Table 2. Lisinopril Market Drivers & Opportunity
    Table 3. Lisinopril Market Challenges
    Table 4. Lisinopril Market Restraints
    Table 5. Global Lisinopril Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Lisinopril Revenue Market Share by Company (2019-2024)
    Table 7. Global Lisinopril Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Lisinopril Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Lisinopril Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Lisinopril Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Lisinopril Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Lisinopril
    Table 13. Global Lisinopril Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisinopril as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Lisinopril Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Lisinopril Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Lisinopril Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Lisinopril Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Lisinopril Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Lisinopril Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Lisinopril Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Lisinopril Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Lisinopril Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Lisinopril Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Lisinopril Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Lisinopril Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Lisinopril Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Lisinopril Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Lisinopril Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Lisinopril Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Lisinopril Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Lisinopril Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Lisinopril Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Lisinopril Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Lisinopril Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Lisinopril Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Lisinopril Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Lisinopril Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Lisinopril Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Lisinopril Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Lisinopril Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Lisinopril Sales Value by Region (2019-2024) & (%)
    Table 44. Global Lisinopril Sales Value by Region (2025-2030) & (%)
    Table 45. Global Lisinopril Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Lisinopril Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Lisinopril Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Lisinopril Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Lisinopril Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Lisinopril Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Lisinopril Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Lisinopril Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Lisinopril Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Lisinopril Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Lisinopril Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Lisinopril Sales Volume, (2025-2030) & (K Units)
    Table 57. Actavis Elizabeth Company Information
    Table 58. Actavis Elizabeth Introduction and Business Overview
    Table 59. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Actavis Elizabeth Lisinopril Product Offerings
    Table 61. Actavis Elizabeth Recent Development
    Table 62. Apotex Company Information
    Table 63. Apotex Introduction and Business Overview
    Table 64. Apotex Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Apotex Lisinopril Product Offerings
    Table 66. Apotex Recent Development
    Table 67. Aurobindo Pharma Company Information
    Table 68. Aurobindo Pharma Introduction and Business Overview
    Table 69. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Aurobindo Pharma Lisinopril Product Offerings
    Table 71. Aurobindo Pharma Recent Development
    Table 72. Ivax Pharmaceuticals Company Information
    Table 73. Ivax Pharmaceuticals Introduction and Business Overview
    Table 74. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Ivax Pharmaceuticals Lisinopril Product Offerings
    Table 76. Ivax Pharmaceuticals Recent Development
    Table 77. Lek Pharmaceuticals Company Information
    Table 78. Lek Pharmaceuticals Introduction and Business Overview
    Table 79. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Lek Pharmaceuticals Lisinopril Product Offerings
    Table 81. Lek Pharmaceuticals Recent Development
    Table 82. Lupin Company Information
    Table 83. Lupin Introduction and Business Overview
    Table 84. Lupin Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Lupin Lisinopril Product Offerings
    Table 86. Lupin Recent Development
    Table 87. Mylan Pharmaceuticals Company Information
    Table 88. Mylan Pharmaceuticals Introduction and Business Overview
    Table 89. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Mylan Pharmaceuticals Lisinopril Product Offerings
    Table 91. Mylan Pharmaceuticals Recent Development
    Table 92. Ranbaxy Pharmaceuticals Company Information
    Table 93. Ranbaxy Pharmaceuticals Introduction and Business Overview
    Table 94. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Ranbaxy Pharmaceuticals Lisinopril Product Offerings
    Table 96. Ranbaxy Pharmaceuticals Recent Development
    Table 97. Novartis Company Information
    Table 98. Novartis Introduction and Business Overview
    Table 99. Novartis Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Novartis Lisinopril Product Offerings
    Table 101. Novartis Recent Development
    Table 102. Teva Pharmaceuticals Company Information
    Table 103. Teva Pharmaceuticals Introduction and Business Overview
    Table 104. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Teva Pharmaceuticals Lisinopril Product Offerings
    Table 106. Teva Pharmaceuticals Recent Development
    Table 107. Vintage Pharmaceuticals Company Information
    Table 108. Vintage Pharmaceuticals Introduction and Business Overview
    Table 109. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Vintage Pharmaceuticals Lisinopril Product Offerings
    Table 111. Vintage Pharmaceuticals Recent Development
    Table 112. Watson Laboratories Company Information
    Table 113. Watson Laboratories Introduction and Business Overview
    Table 114. Watson Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Watson Laboratories Lisinopril Product Offerings
    Table 116. Watson Laboratories Recent Development
    Table 117. West Ward Pharmaceutical Company Information
    Table 118. West Ward Pharmaceutical Introduction and Business Overview
    Table 119. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. West Ward Pharmaceutical Lisinopril Product Offerings
    Table 121. West Ward Pharmaceutical Recent Development
    Table 122. Wockhardt Company Information
    Table 123. Wockhardt Introduction and Business Overview
    Table 124. Wockhardt Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Wockhardt Lisinopril Product Offerings
    Table 126. Wockhardt Recent Development
    Table 127. Merck Research Laboratories Company Information
    Table 128. Merck Research Laboratories Introduction and Business Overview
    Table 129. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Merck Research Laboratories Lisinopril Product Offerings
    Table 131. Merck Research Laboratories Recent Development
    Table 132. Astrazeneca Company Information
    Table 133. Astrazeneca Introduction and Business Overview
    Table 134. Astrazeneca Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Astrazeneca Lisinopril Product Offerings
    Table 136. Astrazeneca Recent Development
    Table 137. Alvogen Company Information
    Table 138. Alvogen Introduction and Business Overview
    Table 139. Alvogen Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Alvogen Lisinopril Product Offerings
    Table 141. Alvogen Recent Development
    Table 142. Hikma Company Information
    Table 143. Hikma Introduction and Business Overview
    Table 144. Hikma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Hikma Lisinopril Product Offerings
    Table 146. Hikma Recent Development
    Table 147. Prinston Company Information
    Table 148. Prinston Introduction and Business Overview
    Table 149. Prinston Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Prinston Lisinopril Product Offerings
    Table 151. Prinston Recent Development
    Table 152. Accord Hlthcare Company Information
    Table 153. Accord Hlthcare Introduction and Business Overview
    Table 154. Accord Hlthcare Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Accord Hlthcare Lisinopril Product Offerings
    Table 156. Accord Hlthcare Recent Development
    Table 157. CASI Pharms Company Information
    Table 158. CASI Pharms Introduction and Business Overview
    Table 159. CASI Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. CASI Pharms Lisinopril Product Offerings
    Table 161. CASI Pharms Recent Development
    Table 162. Invagen Pharms Company Information
    Table 163. Invagen Pharms Introduction and Business Overview
    Table 164. Invagen Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 165. Invagen Pharms Lisinopril Product Offerings
    Table 166. Invagen Pharms Recent Development
    Table 167. SUN Pharm Company Information
    Table 168. SUN Pharm Introduction and Business Overview
    Table 169. SUN Pharm Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 170. SUN Pharm Lisinopril Product Offerings
    Table 171. SUN Pharm Recent Development
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Lisinopril Downstream Customers
    Table 175. Lisinopril Distributors List
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Lisinopril Product Picture
    Figure 2. Global Lisinopril Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Lisinopril Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Lisinopril Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Lisinopril Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Lisinopril Report Years Considered
    Figure 7. Global Lisinopril Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Lisinopril Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lisinopril Revenue in 2023
    Figure 10. Lisinopril Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 2.5mg Picture
    Figure 12. 5mg Picture
    Figure 13. 10mg Picture
    Figure 14. 20mg Picture
    Figure 15. 30mg Picture
    Figure 16. 40mg Picture
    Figure 17. Global Lisinopril Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Lisinopril Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Lisinopril Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Lisinopril Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Lisinopril Price by Type (2019-2030) & (US$/Unit)
    Figure 22. Product Picture of Hospital
    Figure 23. Product Picture of Drug Store
    Figure 24. Global Lisinopril Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Lisinopril Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Lisinopril Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Lisinopril Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Lisinopril Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Lisinopril Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Lisinopril Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Lisinopril Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Lisinopril Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Lisinopril Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Lisinopril Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Lisinopril Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Lisinopril Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Lisinopril Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Lisinopril Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Lisinopril Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Lisinopril Sales Volume (%), (2019-2030)
    Figure 41. United States Lisinopril Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Lisinopril Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Lisinopril Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Lisinopril Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Lisinopril Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Lisinopril Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Lisinopril Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Lisinopril Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Lisinopril Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Lisinopril Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Lisinopril Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Lisinopril Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Lisinopril Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Lisinopril Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Lisinopril Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Lisinopril Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Lisinopril Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Lisinopril Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Lisinopril Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Lisinopril Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Lisinopril Sales Value by Application (%), 2023 VS 2030
    Figure 62. Lisinopril Industrial Chain
    Figure 63. Lisinopril Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS